Enanta Pharmaceuticals Inc (ENTA)
4.69
+0.43
(+10.09%)
USD |
NASDAQ |
Apr 11, 16:00
4.70
+0.01
(+0.21%)
After-Hours: 20:00
Enanta Pharmaceuticals Shareholders Equity (Quarterly): 111.82M for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Recursion Pharmaceuticals Inc | 1.035B |
| Moderna Inc | 10.90B |
| Perspective Therapeutics Inc | 290.67M |
| NovaBay Pharmaceuticals Inc | -0.129M |
| Palatin Technologies Inc | -6.381M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 348.64M |
| Total Liabilities (Quarterly) | 236.83M |
| Current Ratio | 5.467 |